 David Price
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Certification | 13 | 2025 | 103 | 6.530 |
Why?
| | Education, Medical, Continuing | 12 | 2025 | 128 | 3.350 |
Why?
| | Specialty Boards | 5 | 2025 | 36 | 2.860 |
Why?
| | Family Practice | 11 | 2025 | 462 | 2.840 |
Why?
| | Clinical Competence | 14 | 2025 | 1100 | 2.310 |
Why?
| | Learning | 7 | 2024 | 415 | 2.020 |
Why?
| | Physicians | 7 | 2023 | 907 | 1.840 |
Why?
| | Educational Measurement | 4 | 2025 | 281 | 1.350 |
Why?
| | Self-Assessment | 2 | 2025 | 74 | 1.140 |
Why?
| | Delivery of Health Care | 3 | 2023 | 944 | 0.940 |
Why?
| | Internship and Residency | 5 | 2024 | 1137 | 0.940 |
Why?
| | Physicians, Family | 2 | 2022 | 201 | 0.800 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2021 | 1327 | 0.800 |
Why?
| | Attitude of Health Personnel | 7 | 2018 | 1162 | 0.700 |
Why?
| | Medicine | 3 | 2018 | 121 | 0.670 |
Why?
| | Hypertension | 6 | 2015 | 1285 | 0.620 |
Why?
| | Motivation | 1 | 2024 | 568 | 0.610 |
Why?
| | Education, Medical | 3 | 2021 | 262 | 0.610 |
Why?
| | Machine Learning | 1 | 2024 | 491 | 0.600 |
Why?
| | Curriculum | 5 | 2021 | 983 | 0.570 |
Why?
| | Allergists | 1 | 2017 | 12 | 0.530 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 482 | 0.530 |
Why?
| | Patient Handoff | 1 | 2017 | 33 | 0.530 |
Why?
| | Allergy and Immunology | 1 | 2017 | 43 | 0.510 |
Why?
| | Surgical Procedures, Operative | 1 | 2019 | 259 | 0.500 |
Why?
| | Diffusion of Innovation | 2 | 2016 | 98 | 0.480 |
Why?
| | Pandemics | 2 | 2022 | 1623 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 368 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 359 | 0.450 |
Why?
| | Antidepressive Agents | 5 | 2018 | 235 | 0.440 |
Why?
| | Hypersensitivity | 1 | 2017 | 257 | 0.420 |
Why?
| | Humans | 46 | 2025 | 137294 | 0.410 |
Why?
| | United States | 11 | 2025 | 14742 | 0.380 |
Why?
| | Depression | 4 | 2018 | 1408 | 0.370 |
Why?
| | Quality Improvement | 4 | 2023 | 1172 | 0.370 |
Why?
| | Primary Health Care | 7 | 2023 | 1724 | 0.340 |
Why?
| | Drug Approval | 1 | 2009 | 87 | 0.310 |
Why?
| | Prescription Drugs | 1 | 2009 | 109 | 0.290 |
Why?
| | Weight Loss | 1 | 2012 | 779 | 0.270 |
Why?
| | Adult | 15 | 2025 | 37724 | 0.240 |
Why?
| | Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2005 | 6 | 0.230 |
Why?
| | Breast Diseases | 1 | 2005 | 22 | 0.230 |
Why?
| | Internet | 1 | 2009 | 651 | 0.230 |
Why?
| | Professional Competence | 1 | 2005 | 100 | 0.230 |
Why?
| | Risk Reduction Behavior | 2 | 2018 | 218 | 0.230 |
Why?
| | Practice Patterns, Physicians' | 3 | 2010 | 1302 | 0.220 |
Why?
| | Quality of Health Care | 2 | 2019 | 635 | 0.210 |
Why?
| | Metformin | 3 | 2018 | 330 | 0.210 |
Why?
| | Referral and Consultation | 2 | 2023 | 778 | 0.210 |
Why?
| | Male | 19 | 2025 | 67560 | 0.200 |
Why?
| | Retrospective Studies | 7 | 2025 | 15639 | 0.200 |
Why?
| | Female | 19 | 2025 | 73052 | 0.190 |
Why?
| | Antihypertensive Agents | 3 | 2015 | 488 | 0.190 |
Why?
| | Health Maintenance Organizations | 2 | 2002 | 97 | 0.190 |
Why?
| | Hospitals, University | 2 | 2002 | 183 | 0.180 |
Why?
| | Health Personnel | 3 | 2023 | 704 | 0.180 |
Why?
| | Accreditation | 1 | 2021 | 83 | 0.180 |
Why?
| | Hypoglycemic Agents | 3 | 2018 | 1283 | 0.170 |
Why?
| | Racism | 2 | 2013 | 135 | 0.170 |
Why?
| | Middle Aged | 13 | 2024 | 33310 | 0.160 |
Why?
| | Diabetes Mellitus | 3 | 2015 | 1036 | 0.150 |
Why?
| | Medical Indigency | 1 | 1998 | 11 | 0.150 |
Why?
| | Educational Technology | 1 | 2018 | 7 | 0.140 |
Why?
| | Education, Distance | 1 | 2018 | 48 | 0.140 |
Why?
| | Blood Pressure | 2 | 2015 | 1776 | 0.140 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5769 | 0.130 |
Why?
| | Colorado | 8 | 2014 | 4527 | 0.130 |
Why?
| | Simulation Training | 1 | 2018 | 99 | 0.120 |
Why?
| | Interprofessional Relations | 2 | 2016 | 283 | 0.120 |
Why?
| | Patient Care | 1 | 2017 | 110 | 0.120 |
Why?
| | C-Reactive Protein | 1 | 2018 | 412 | 0.120 |
Why?
| | Choice Behavior | 1 | 2017 | 171 | 0.120 |
Why?
| | Patient Safety | 1 | 2018 | 309 | 0.110 |
Why?
| | Surgeons | 1 | 2019 | 297 | 0.110 |
Why?
| | Psychotherapy, Brief | 1 | 2014 | 34 | 0.110 |
Why?
| | Organizational Culture | 1 | 2015 | 146 | 0.110 |
Why?
| | Interleukin-6 | 1 | 2018 | 778 | 0.100 |
Why?
| | Medication Adherence | 2 | 2015 | 468 | 0.100 |
Why?
| | Workload | 1 | 2015 | 161 | 0.100 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2850 | 0.100 |
Why?
| | Research | 1 | 2016 | 449 | 0.100 |
Why?
| | Blood Pressure Determination | 1 | 2014 | 156 | 0.100 |
Why?
| | Patient Satisfaction | 2 | 2013 | 657 | 0.100 |
Why?
| | Dyslipidemias | 1 | 2014 | 176 | 0.100 |
Why?
| | Pilot Projects | 3 | 2014 | 1700 | 0.100 |
Why?
| | Prospective Studies | 1 | 2024 | 7595 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2018 | 2516 | 0.090 |
Why?
| | Prediabetic State | 1 | 2015 | 253 | 0.090 |
Why?
| | Physician-Patient Relations | 2 | 2013 | 548 | 0.090 |
Why?
| | Body Weight | 2 | 2012 | 985 | 0.090 |
Why?
| | Decision Making, Computer-Assisted | 1 | 2010 | 18 | 0.090 |
Why?
| | Telemedicine | 1 | 2020 | 854 | 0.090 |
Why?
| | Veins | 1 | 2010 | 62 | 0.080 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2010 | 84 | 0.080 |
Why?
| | Medical Records Systems, Computerized | 1 | 2010 | 92 | 0.080 |
Why?
| | Antifibrinolytic Agents | 1 | 2010 | 51 | 0.080 |
Why?
| | Patient Care Team | 1 | 2015 | 629 | 0.080 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 235 | 0.080 |
Why?
| | Medically Uninsured | 2 | 2002 | 129 | 0.080 |
Why?
| | Off-Label Use | 1 | 2009 | 52 | 0.080 |
Why?
| | Communication | 1 | 2015 | 879 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1577 | 0.080 |
Why?
| | Obstetrics | 1 | 2010 | 163 | 0.070 |
Why?
| | Patient-Centered Care | 1 | 2013 | 523 | 0.070 |
Why?
| | Gynecology | 1 | 2010 | 176 | 0.070 |
Why?
| | Internal Medicine | 1 | 2010 | 253 | 0.070 |
Why?
| | Problem-Based Learning | 1 | 2008 | 90 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2658 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2014 | 982 | 0.070 |
Why?
| | Inflammation | 1 | 2018 | 2836 | 0.060 |
Why?
| | Venous Thromboembolism | 1 | 2010 | 313 | 0.060 |
Why?
| | Mass Screening | 1 | 2014 | 1268 | 0.060 |
Why?
| | Information Dissemination | 1 | 2008 | 217 | 0.060 |
Why?
| | Substance-Related Disorders | 1 | 2014 | 1073 | 0.060 |
Why?
| | Models, Educational | 1 | 2025 | 93 | 0.060 |
Why?
| | Periodicals as Topic | 1 | 2008 | 211 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2025 | 170 | 0.060 |
Why?
| | Qualitative Research | 1 | 2010 | 1367 | 0.050 |
Why?
| | Language | 1 | 2025 | 298 | 0.050 |
Why?
| | Linear Models | 1 | 2005 | 846 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 179 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2025 | 277 | 0.050 |
Why?
| | Canada | 1 | 2023 | 421 | 0.050 |
Why?
| | Pediatrics | 1 | 2010 | 1113 | 0.050 |
Why?
| | Health Care Surveys | 2 | 2013 | 564 | 0.040 |
Why?
| | Publications | 1 | 2021 | 47 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2021 | 74 | 0.040 |
Why?
| | Continuity of Patient Care | 2 | 2002 | 280 | 0.040 |
Why?
| | Guideline Adherence | 1 | 2004 | 549 | 0.040 |
Why?
| | Kidney Failure, Chronic | 1 | 2004 | 566 | 0.040 |
Why?
| | Systems Integration | 1 | 1998 | 37 | 0.040 |
Why?
| | Eligibility Determination | 1 | 2018 | 65 | 0.040 |
Why?
| | Total Quality Management | 1 | 1998 | 61 | 0.040 |
Why?
| | Information Systems | 1 | 1998 | 61 | 0.040 |
Why?
| | Financing, Government | 1 | 1998 | 46 | 0.040 |
Why?
| | Interinstitutional Relations | 1 | 1998 | 54 | 0.040 |
Why?
| | Personnel Staffing and Scheduling | 1 | 1998 | 94 | 0.030 |
Why?
| | Specialization | 1 | 1998 | 143 | 0.030 |
Why?
| | Healthcare Disparities | 2 | 2014 | 652 | 0.030 |
Why?
| | Aged | 5 | 2018 | 23851 | 0.030 |
Why?
| | Formative Feedback | 1 | 2016 | 28 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2016 | 205 | 0.030 |
Why?
| | Program Development | 1 | 2018 | 365 | 0.030 |
Why?
| | Health Policy | 1 | 1998 | 389 | 0.030 |
Why?
| | Animals | 1 | 2017 | 36862 | 0.030 |
Why?
| | Risk Factors | 3 | 2015 | 10368 | 0.030 |
Why?
| | Minnesota | 1 | 2014 | 162 | 0.030 |
Why?
| | Program Evaluation | 1 | 1998 | 891 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 1994 | 187 | 0.030 |
Why?
| | Diabetic Angiopathies | 1 | 2015 | 259 | 0.030 |
Why?
| | Stereotyped Behavior | 1 | 2012 | 19 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1624 | 0.020 |
Why?
| | Cultural Competency | 1 | 2013 | 87 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1059 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 1994 | 586 | 0.020 |
Why?
| | Patient Participation | 1 | 2014 | 417 | 0.020 |
Why?
| | Decision Making | 1 | 2017 | 898 | 0.020 |
Why?
| | Research Design | 1 | 2016 | 1128 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2373 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 497 | 0.020 |
Why?
| | Models, Statistical | 1 | 2013 | 670 | 0.020 |
Why?
| | Venous Thrombosis | 1 | 2010 | 190 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2010 | 562 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2010 | 226 | 0.020 |
Why?
| | Outpatients | 1 | 2010 | 394 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 2715 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5436 | 0.020 |
Why?
| | Electronic Health Records | 1 | 2014 | 1045 | 0.020 |
Why?
| | Ultrasonography | 1 | 2010 | 752 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 1998 | 2054 | 0.020 |
Why?
| | Young Adult | 2 | 2013 | 13163 | 0.020 |
Why?
| | Life Style | 1 | 2007 | 488 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5125 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 2004 | 29 | 0.010 |
Why?
| | Time Factors | 1 | 2015 | 6818 | 0.010 |
Why?
| | Medication Errors | 1 | 2004 | 97 | 0.010 |
Why?
| | Adolescent | 2 | 2013 | 21499 | 0.010 |
Why?
| | Drug Utilization | 1 | 2004 | 170 | 0.010 |
Why?
| | Age Factors | 1 | 2010 | 3297 | 0.010 |
Why?
| | Utilization Review | 1 | 2002 | 36 | 0.010 |
Why?
| | Financing, Personal | 1 | 2002 | 26 | 0.010 |
Why?
| | State Health Plans | 1 | 2002 | 30 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2015 | 10800 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2004 | 539 | 0.010 |
Why?
| | Inpatients | 1 | 2004 | 503 | 0.010 |
Why?
| | Health Services Research | 1 | 2002 | 402 | 0.010 |
Why?
| | Medicaid | 1 | 2002 | 434 | 0.010 |
Why?
|
|
Price's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|